Literature DB >> 28221202

Arginine Therapy Shows Promise for Treatment of Sickle Cell Disease Clinical Subphenotypes of Hemolysis and Arginine Deficiency.

Claudia R Morris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28221202      PMCID： PMC5359054          DOI： 10.1213/ANE.0000000000001874

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  5 in total

1.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

Review 2.  Alterations of the arginine metabolome in sickle cell disease: a growing rationale for arginine therapy.

Authors:  Claudia R Morris
Journal:  Hematol Oncol Clin North Am       Date:  2014-04       Impact factor: 3.722

3.  Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?

Authors:  Claudia R Morris; Sidney M Morris; Ward Hagar; Jane Van Warmerdam; Susan Claster; Diane Kepka-Lenhart; Lorenzo Machado; Frans A Kuypers; Elliott P Vichinsky
Journal:  Am J Respir Crit Care Med       Date:  2003-03-05       Impact factor: 21.405

4.  Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice.

Authors:  Jochen Steppan; Huong T Tran; Valeriani R Bead; Young Jun Oh; Gautam Sikka; Trinity J Bivalacqua; Arthur L Burnett; Dan E Berkowitz; Lakshmi Santhanam
Journal:  Anesth Analg       Date:  2016-09       Impact factor: 5.108

5.  Hematologic, biochemical, and cardiopulmonary effects of L-arginine supplementation or phosphodiesterase 5 inhibition in patients with sickle cell disease who are on hydroxyurea therapy.

Authors:  Jane A Little; Kristine Partovi Hauser; Sabrina E Martyr; Amy Harris; Irina Maric; Claudia R Morris; Jung H Suh; James Taylor; Oswaldo Castro; Roberto Machado; Gregory Kato; Mark T Gladwin
Journal:  Eur J Haematol       Date:  2008-02-10       Impact factor: 2.997
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.